Evaxion Biotech A/S (EVAX) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free EVAX Stock Alerts $4.13 -0.01 (-0.24%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEvaxion Biotech A (EVAX) Price Target Decreased by 13.62% to 11.99msn.com - April 17 at 8:21 PMEvaxion Biotech: Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01finanznachrichten.de - April 17 at 10:19 AMEvaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01finance.yahoo.com - April 17 at 10:19 AMEvaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01globenewswire.com - April 17 at 8:00 AMHead-To-Head Survey: Compass Therapeutics (NASDAQ:CMPX) & Evaxion Biotech A/S (NASDAQ:EVAX)americanbankingnews.com - April 17 at 1:16 AMHead-To-Head Survey: Evaxion Biotech A/S (NASDAQ:EVAX) versus Jasper Therapeutics (NASDAQ:JSPR)americanbankingnews.com - April 15 at 1:44 AMQ4 2023 Evaxion Biotech A/S Earnings Call (Danish)finance.yahoo.com - April 3 at 2:15 PMEvaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 3 at 9:15 AMADRs End Lower; Meta Data Slides 22%marketwatch.com - April 2 at 5:44 PMEvaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infectionglobenewswire.com - April 2 at 7:00 AMEvaxion Biotech: Evaxion Announces Business Update and Full Year 2023 Financial Resultsfinanznachrichten.de - March 28 at 12:08 AMEVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023investorplace.com - March 27 at 1:52 PMEvaxion Announces Business Update and Full Year 2023 Financial Resultsglobenewswire.com - March 27 at 7:30 AMWhen Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?finance.yahoo.com - March 22 at 12:09 PMBuy Rating Affirmed for Evaxion Biotech Amid AI-Driven Vaccine Development Milestonesmarkets.businessinsider.com - March 20 at 7:30 PMEvaxion Biotech: Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology Platformfinanznachrichten.de - March 19 at 8:12 AMEvaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platformglobenewswire.com - March 19 at 7:30 AMNeuroBo Phase 2a study for MASH drug to proceed as plannedmsn.com - March 13 at 1:12 PMEvaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovationsglobenewswire.com - February 29 at 7:30 AMEvaxion Biotech A (EVAX) Price Target Increased by 414.29% to 18.36msn.com - February 24 at 5:40 AMEvaxion Biotech: Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSDfinanznachrichten.de - February 20 at 10:18 AMEvaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSDfinance.yahoo.com - February 20 at 10:18 AMEvaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSDglobenewswire.com - February 20 at 7:30 AMBuy Rating for Evaxion Biotech: AI Revolutionizing Immunotherapy and Vaccine Developmentmarkets.businessinsider.com - February 12 at 11:30 PMEvaxion Biotech AS (EVAX)investing.com - February 7 at 1:57 PMEvaxion Regains Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - February 7 at 8:57 AMEvaxion Biotech: Evaxion Announces Closing of $15 Million Public Offeringfinanznachrichten.de - February 6 at 12:50 PMEvaxion Announces Closing of $15 Million Public Offeringfinance.yahoo.com - February 6 at 12:50 PMEvaxion Biotech to raise ~$15M through public offering of shares and warrantsmsn.com - February 1 at 2:49 PMmarketbeat.com - February 1 at 9:52 AMEvaxion Biotech Announces Pricing of $15 Million Public Offeringfinance.yahoo.com - February 1 at 9:48 AMmarketbeat.com - February 1 at 9:37 AMmarketbeat.com - January 29 at 9:44 AMEvaxion Biotech to develop new vaccines for cancermsn.com - January 25 at 7:13 PMADRs Close Higher, Evaxion Biotech A/S Climbs 113.4%morningstar.com - January 24 at 7:16 PMEvaxion stock rallies 120% on AI-based cancer vaccine programmsn.com - January 24 at 2:16 PMmarketbeat.com - January 24 at 10:17 AMmarketbeat.com - January 24 at 10:05 AMmarketbeat.com - January 24 at 9:50 AMEvaxion Biotech: Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targetsfinanznachrichten.de - January 24 at 9:15 AMEvaxion ADSs Rise 17% After ADS Ratio Changemarketwatch.com - January 24 at 9:15 AMEvaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targetsfinance.yahoo.com - January 24 at 9:15 AMmarketbeat.com - January 23 at 9:33 AMEvaxion Biotech: Evaxion Announces Completion of ADS Ratio Changefinanznachrichten.de - January 22 at 6:44 PMADRs End Lower; Evaxion Biotech A/S Drops 45%morningstar.com - January 22 at 6:44 PMEvaxion Announces Completion of ADS Ratio Changefinance.yahoo.com - January 22 at 6:43 PMmarketbeat.com - January 22 at 11:55 AMmarketbeat.com - January 22 at 6:00 AMEvaxion Announces Plan to Implement ADS Ratio Changefinance.yahoo.com - January 8 at 8:36 AMEvaxion Biotech Announces Closing of Private Placementfinance.yahoo.com - December 21 at 6:04 PM Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now EVAX Media Mentions By Week EVAX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVAX News Sentiment▼-0.340.43▲Average Medical News Sentiment EVAX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVAX Articles This Week▼11▲EVAX Articles Average Week Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ZIVO Bioscience News Today AIM ImmunoTech News Today Aptose Biosciences News Today Pluri News Today Windtree Therapeutics News Today Surrozen News Today Senti Biosciences News Today MiNK Therapeutics News Today Coeptis Therapeutics News Today Achilles Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVAX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
